Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 30-33 , July 2010

Loose seeds versus stranded seeds in I-125 prostate brachytherapy: Differences in clinical outcome

Received 15 May 2009 ,Revised 8 January 2010 ,Accepted 13 February 2010.

References 

  1. Van Gellekom MP, Moerland MA, Wijrdeman HK, Battermann JJ. Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID strands. Radiother Oncol. 2004;73:49–56
  2. Moerland MA, van Deursen MJ, Elias SG, van Vulpen M, Jurgenliemk-Schulz IM, Battermann JJ. Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants. Radiother Oncol. 2009;91:202–206
  3. Haffner J, Potiron E, Bouye S, et al. Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology. Prostate. 2009;69:276–282
  4. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM radiation therapy committee task group no. 43. Med Phys. 1995;22:209–234
  5. Roach M, Hanks G, Thames H, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys. 2006;65:965–974
  6. Ash D, Flynn A, Battermann JJ, Reijke TD, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol. 2000;57:315–321
  7. Fagundes HM, Keys RJ, Wojcik MF, Radden MA, Bertelsman CG, Cavanagh WA. Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPIDStrand: a dosimetric analysis. Brachytherapy. 2004;3:136–140
  8. Heysek RV, Gwede CK, Torres-Roca J, et al. A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy. Brachytherapy. 2006;5:244–250
  9. Lee WR, deGuzman AF, Tomlinson SK, McCullough DL. Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy. Radiother Oncol. 2002;65:123–127
  10. Fuller DB, Koziol JA, Feng AC. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. Brachytherapy. 2004;3:10–19
  11. Saibishkumar EP, Borg J, Yeung I, Cummins-Holder C, Landon A, Crook J. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009;73:61–68
  12. Crook J, Pearson S, Williams T. The pros and cons of linked vs loose seeds. CARO Annual Meeting. Montreal, Canada, October 3–5, 2003. Radiother Oncol. 2003;69(Suppl. 1):157
  13. Reed DR, Wallner KE, Merrick GS, et al. A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapy. Brachytherapy. 2007;6:129–134
  14. Ash D, Al-Qaisieh B, Bottomley D, Carey B, Joseph J. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. Radiother Oncol. 2006;79:185–189
  15. Stock RG, Stone NN, Tabert A, Iannuzzi C, DeWyngaert JK. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 1998;41:101–108
  16. McLaughlin P, Narayana V, Pan C, et al. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds. Int J Radiat Oncol Biol Phys. 2006;64:144–150

PII: S0167-8140(10)00105-2

doi: 10.1016/j.radonc.2010.02.012

Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 30-33 , July 2010

Article Tools

* Image Usage & Resolution